Orthotopic liver transplantation with poor neurologic outcome in valproate-associated liver failure: A need for critical risk-benefit appraisal in the use of valproate

被引：14
|
作者：
Thomson, MA
Lynch, S
Strong, R
Shepherd, RW
Marsh, W
机构：
[1] Royal Childrens Hosp, Queensland Liver Transplant Serv, Brisbane, Qld, Australia
[2] Univ Pittsburgh, Pittsburgh Transplant Inst, Pittsburgh, PA 15213 USA
来源：
TRANSPLANTATION PROCEEDINGS | 2000年 / 32卷 / 01期
关键词：
D O I：
10.1016/S0041-1345(99)00936-7
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：200 / 203
页数：4
相关论文
共 9 条
  • [1] TREATMENT OF VALPROATE-ASSOCIATED LIVER-FAILURE WITH PLASMAPHERESIS
    BENNINGER, C
    HAFFNER, D
    EBERLE, T
    RAU, W
    EPILEPSIA, 1995, 36 : S68 - S68
  • [2] UNUSUAL ELECTRON-MICROSCOPIC CHANGES IN VALPROATE-ASSOCIATED LIVER-FAILURE
    CAPARROSLEFEBVRE, D
    LECOMTEHOUCKE, M
    PRUVOT, FR
    DECLERCK, N
    PARIS, JC
    PETIT, H
    LANCET, 1993, 341 (8860): : 1604 - 1604
  • [3] Predicting the outcome of liver transplantation in patients with non-alcoholic steatohepatitis cirrhosis: The NASH LT risk-benefit calculator
    Karnam, Ravikiran S. S.
    Punchhi, Gopika
    Mitsakakis, Nicholas
    Chen, Shiyi
    Saracino, Giovanna
    Lilly, Leslie
    Asrani, Sumeet K. K.
    Bhat, Mamatha
    CLINICAL TRANSPLANTATION, 2023, 37 (04)
  • [4] Impact of Rotational Thromboelastometry on Blood Use and Patient Outcome in High-Risk Orthotopic Liver Transplantation
    Chang, S.
    Kwok, W. A.
    Ward, D. C.
    Ziman, A.
    McGonigle, A. M.
    TRANSFUSION, 2016, 56 : 106A - 106A
  • [5] EEG Abnormalities Are Associated With Increased Risk of Transplant or Poor Outcome in Children With Acute Liver Failure
    Hussain, Elora
    Grimason, Michele
    Goldstein, Joshua
    Smith, Craig M.
    Alonso, Estella
    Whitington, Peter F.
    Wainwright, Mark S.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2014, 58 (04): : 449 - 456
  • [6] LATE-ONSET ACUTE REJECTION IN ORTHOTOPIC LIVER-TRANSPLANTATION - ASSOCIATED RISK-FACTORS AND OUTCOME
    MOR, E
    GONWA, TA
    HUSBERG, BS
    GOLDSTEIN, RM
    KLINTMALM, GB
    TRANSPLANTATION, 1992, 54 (05) : 821 - 824
  • [7] BETA-BLOCKER USE IS ASSOCIATED WITH AN INCREASED EARLY RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS AFTER ORTHOTOPIC LIVER TRANSPLANTATION
    Koshy, Anoop Ninan
    Gow, Paul J.
    Cailes, Benjamin
    Ko, Jefferson
    Han, Hui-Chen
    Weinberg, Laurence
    Testro, Adam
    Teh, Andrew W.
    Farouque, Omar
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1942 - 1942
  • [8] Use of Steroids after Liver Transplantation Is Associated with Lower Risk of Early Graft Failure (EGF): Insights from the Liver Match Prospective Study.
    Angelico, Mario
    Marianelli, Tania
    Cillo, Umberto
    Fagiuoli, Stefano
    Gasbarrini, Antonio
    Strazzabosco, Mario
    Nardi, Alessandra
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 532 - 533
  • [9] The use of the King's College Hospital criteria (KCHC) on admission to predict mortality or the need for orthotopic liver transplantation (OLT) in patients referred to Emory University Hospital (EUH) for fulminant hepatic failure (FHF).
    Fenton, PC
    Bruno, CJ
    Ricci, P
    GASTROENTEROLOGY, 2001, 120 (05) : A542 - A542
1